A new version of ResearchHub is available.Try it now
Paper
0
1296 Tumor-activated immune cell engagers designed to drive synthetic immunity against cancer demonstrated protease-dependent activation and robust anti-tumor activity in preclinical models
Authors
Justin Greene,Parker Johnson
Wilson Guzman,Natalia Malkova,Amanda Baumholtz,Manoussa Fanny,Damiano Fantini,Jason Hedges,Kurt Jenkins,Jimit Lakhani,Bernard Lanter,Janice Lee,Caitlin O’Toole,Lisa Quinn,Rosa Quiroz,Kerri Smith,Sallyann Vu,Oleg Yerov,Sylvia Coleman,Bruce Nicholson
+18 authors
,Carl BialuchaPublished
Nov 1, 2024
Show more
Save
Tip0
TipSave
Abstract
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.